Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04807972
Title Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Age Groups: adult | senior
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
UCHSC Anschultz Cancer Pavilion /ID# 227841 Aurora Colorado 80045-2517 United States Details
Johns Hopkins University /ID# 226713 Baltimore Maryland 21287 United States Details
Univ Hosp Cleveland /ID# 226807 Cleveland Ohio 44106 United States Details
Cleveland Clinic Main Campus /ID# 231135 Cleveland Ohio 44195 United States Details
Penn State Hershey Medical Ctr /ID# 229837 Hershey Pennsylvania 17033-2360 United States Details
Monash Medical Centre /ID# 231379 Clayton Victoria 3168 Australia Details
Austin Health /ID# 231378 Heidelberg Victoria 3084 Australia Details
The Chaim Sheba Medical Center /ID# 226812 Ramat Gan Tel-Aviv 5265601 Israel Details
Rambam Health Care Campus /ID# 229555 Haifa 3109601 Israel Details
Yonsei University Health System Severance Hospital /ID# 230280 Seoul Seoul Teugbyeolsi 03722 Korea, Republic of Details
Asan Medical Center /ID# 230282 Seoul 05505 Korea, Republic of Details
Pan American Center for Oncology Trials, LLC /ID# 228210 Rio Piedras 00935 Puerto Rico Details
Hospital Universitario Vall d'Hebron /ID# 230226 Barcelona 08035 Spain Details
Hospital Universitario 12 de Octubre /ID# 230102 Madrid 28041 Spain Details
Hospital Universitario Miguel Servet /ID# 230139 Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from for the field